このアイテムのアクセス数: 275

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-022-35346-7.pdf3.09 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorKawai, Hiroyukien
dc.contributor.authorBouchekioua, Youcefen
dc.contributor.authorNishitani, Naoyaen
dc.contributor.authorNiitani, Kazuheien
dc.contributor.authorIzumi, Shomaen
dc.contributor.authorMorishita, Hinakoen
dc.contributor.authorAndoh, Chihiroen
dc.contributor.authorNagai, Yumaen
dc.contributor.authorKoda, Masashien
dc.contributor.authorHagiwara, Masakoen
dc.contributor.authorToda, Kojien
dc.contributor.authorShirakawa, Hisashien
dc.contributor.authorNagayasu, Kazukien
dc.contributor.authorOhmura, Yuen
dc.contributor.authorKondo, Makotoen
dc.contributor.authorKaneda, Katsuyukien
dc.contributor.authorYoshioka, Mitsuhiroen
dc.contributor.authorKaneko, Shujien
dc.contributor.alternative河合, 洋幸ja
dc.contributor.alternativeブシェキワ, ユセフja
dc.contributor.alternative西谷, 直也ja
dc.contributor.alternative二井谷, 和平ja
dc.contributor.alternative泉, 翔馬ja
dc.contributor.alternative森下, 雛子ja
dc.contributor.alternative安藤, 千紘ja
dc.contributor.alternative永井, 佑茉ja
dc.contributor.alternative好田, 匡志ja
dc.contributor.alternative萩原, 雅子ja
dc.contributor.alternative兎田, 幸司ja
dc.contributor.alternative白川, 久志ja
dc.contributor.alternative永安, 一樹ja
dc.contributor.alternative大村, 優ja
dc.contributor.alternative近藤, 誠ja
dc.contributor.alternative金田, 勝幸ja
dc.contributor.alternative吉岡, 充弘ja
dc.contributor.alternative金子, 周司ja
dc.date.accessioned2022-12-27T05:28:32Z-
dc.date.available2022-12-27T05:28:32Z-
dc.date.issued2022-
dc.identifier.urihttp://hdl.handle.net/2433/278124-
dc.description不快感を誘発するセロトニン神経を発見 --セロトニン神経の多様性が明らかに--. 京都大学プレスリリース. 2022-12-23.ja
dc.description.abstractAppropriate processing of reward and aversive information is essential for survival. Although a critical role of serotonergic neurons in the dorsal raphe nucleus (DRN) in reward processing has been shown, the lack of rewarding effects with selective serotonin reuptake inhibitors (SSRIs) implies the presence of a discrete serotonergic system playing an opposite role to the DRN in the processing of reward and aversive stimuli. Here, we demonstrated that serotonergic neurons in the median raphe nucleus (MRN) of mice process reward and aversive information in opposite directions to DRN serotonergic neurons. We further identified MRN serotonergic neurons, including those projecting to the interpeduncular nucleus (5-HTMRN→IPN), as a key mediator of reward and aversive stimuli. Moreover, 5-HT receptors, including 5-HT2A receptors in the interpeduncular nucleus, are involved in the aversive properties of MRN serotonergic neural activity. Our findings revealed an essential function of MRN serotonergic neurons, including 5-HTMRN→IPN, in the processing of reward and aversive stimuli.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2022en
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectNeuroscienceen
dc.subjectRewarden
dc.titleMedian raphe serotonergic neurons projecting to the interpeduncular nucleus control preference and aversionen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume13-
dc.relation.doi10.1038/s41467-022-35346-7-
dc.textversionpublisher-
dc.identifier.artnum7708-
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University; Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka Metropolitan Universityen
dc.addressDepartment of Neuropharmacology, Faculty of Medicine and Graduate School of Medicine, Hokkaido Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University; Department of Neuropharmacology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University; Laboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa Universityen
dc.addressLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa Universityen
dc.addressLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Psychology, Keio Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.addressDepartment of Neuropharmacology, Faculty of Medicine and Graduate School of Medicine, Hokkaido Universityen
dc.addressDepartment of Anatomy and Neuroscience, Graduate School of Medicine, Osaka Metropolitan Universityen
dc.addressLaboratory of Molecular Pharmacology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa Universityen
dc.addressDepartment of Neuropharmacology, Faculty of Medicine and Graduate School of Medicine, Hokkaido Universityen
dc.addressDepartment of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.identifier.pmid36550097-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2022-12-23-0-
dcterms.accessRightsopen access-
datacite.awardNumber20H04774-
datacite.awardNumber20K07064-
datacite.awardNumber18H04616-
datacite.awardNumber20H00491-
datacite.awardNumber21K07473-
datacite.awardNumber21H02668-
datacite.awardNumber22K11498-
datacite.awardNumber20J12341-
datacite.awardNumber21J14215-
datacite.awardNumber21J21091-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PUBLICLY-20H04774/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K07064/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PUBLICLY-18H04616/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20H00491/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K07473/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H02668/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K11498/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20J12341/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21J14215/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21J21091/-
dc.identifier.eissn2041-1723-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitle低分子から中分子に至るあらゆる化学構造のヒト作用予測モデルの開発ja
jpcoar.awardTitleうつ病態発症・治療の決定因子の同定ja
jpcoar.awardTitle化学物質の薬効・副作用発現を予測するプラットフォームの確立ja
jpcoar.awardTitleリアルワールドデータの解析に基づく副作用機序の解明と疾患治療標的の発見ja
jpcoar.awardTitleIn vivoゲノム編集による「うつ病のセロトニン仮説」検証ja
jpcoar.awardTitle正中縫線核セロトニン合成能低下による海馬機能低下とうつ様行動増加仮説の検証ja
jpcoar.awardTitle運動の質や種類に着目した運動が脳にもたらす有益効果とそのメカニズムの解析ja
jpcoar.awardTitleセロトニン神経活動の光計測/光操作による不安制御回路の同定と創薬への応用ja
jpcoar.awardTitleうつ病の病態発症及び抗うつ作用発現を司るセロトニン神経回路網とその分子機構の解明ja
jpcoar.awardTitle背側縫線核セロトニン神経の網羅的遺伝子解析によるうつ病の分子メカニズム解明ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons